Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBC [Phase 2]
Phase 2 trial evaluating SHR-1210 (anti-PD-1) with apatinib in advanced triple-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) [Phase 2]
Phase 2 imaging trial evaluating [68Ga]-NeoBOMB1 for GRPR-expressing tumors has terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer [NA]
Clinical trial update for HylaCare in treating acute skin changes during radiotherapy for breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial updating the use of sorafenib with paclitaxel in metastatic breast cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients [Phase 3]
Phase 3 randomized trial comparing tamoxifen alone versus tamoxifen with aminoglutethimide in postmenopausal receptor-positive early-stage b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients [Phase 3]
Phase 3 randomized trial comparing pre- and postoperative versus conventional adjuvant treatment in receptor-negative early stage breast can…
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel [Phase 3]
Phase 3 trial evaluating cetirizine as a replacement for diphenhydramine to prevent reactions related to paclitaxel in cancer patients; stud…
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China [Phase 4]
Phase 4 interventional study of Aromasin in early invasive breast cancer patients in China has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Weekly Single Fraction Hypofractionated Adjuvant Radiotherapy for Early Stage Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating weekly single-fraction hypofractionated adjuvant radiotherapy for early stage breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Effects a Honey Based Syrup on Blood Parameters in Patients With Breast Cancer [Phase 2]
A phase 2 clinical trial evaluating a honey-based syrup's effects on blood parameters in patients with breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Cytokine Expression During Radiation for Breast Cancer [NA]
A completed clinical trial evaluating cytokine expression during radiation therapy for breast cancer; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Management Radiodermatitis in Patients With Breast or Head and Neck Cancer [Phase 3]
Phase 3 clinical trial update on management of radiodermatitis in patients with breast or head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer [Phase 4]
Phase 4 trial update for palbociclib in combination with letrozole in postmenopausal women with HR+, HER2- advanced breast cancer; study com…
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating intra-hepatic chemotherapy in patients with non-resectable liver metastases from metastatic breast …
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating nicotine patches to reduce hand-foot syndrome in patients with metastatic breast cancer receiving capecitabine; t…
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes [NA]
Clinical trial evaluating Magseed as a localization device for biopsy-proven metastatic axillary lymph nodes in breast cancer was terminated…
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)
An update on a breast cancer trial reports psychosocial outcomes and contralateral prophylactic mastectomy; results were posted on 2020-10-0…
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study) [Phase 2]
Phase 2 clinical trial update evaluating letrozole with metronomic capecitabine in ER-positive, HER2-negative advanced/metastatic breast can…
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure [Phase 2]
Phase 2 trial evaluating durvalumab in combination with endocrine therapy for ER+/HER2- breast cancer after an immune-attractant exposure; s…
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer [Phase 2]
Phase 2 trial evaluating tucatinib with capecitabine and trastuzumab in advanced HER2-positive breast cancer has completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer [Phase 3]
A Phase 3 trial evaluating pertuzumab in combination with trastuzumab and a taxane as first-line therapy for HER2-positive advanced breast c…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer [Phase 2]
Phase II trial update for PM01183 in BRCA1/2-associated or unselected metastatic breast cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-24Clinical Trial Update: Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer [Phase 2]
A Phase 2 trial comparing paclitaxel and bevacizumab with enzastaurin versus paclitaxel and bevacizumab with placebo for breast cancer has b…
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer [Phase 3]
A Phase 3 trial assessed adding trastuzumab to chemotherapy after surgery in women with invasive breast cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer [Phase 2]
Phase 2 trial evaluating exemestane in postmenopausal women with stage IV breast cancer has completed with results posted.